Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Change in Cash: 2023

Historic Change in Cash for ADC Therapeutics (ADCT) over the last 1 years, with Dec 2023 value amounting to -$32.0 million.

  • ADC Therapeutics' Change in Cash was N/A to -$32.0 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$48.0 million, marking a year-over-year change of. This contributed to the annual value of -$27.6 million for FY2024, which is 42.43% up from last year.
  • ADC Therapeutics' Change in Cash amounted to -$32.0 million in Q4 2023, which was up 13.58% from -$37.0 million recorded in Q3 2023.
  • In the past 5 years, ADC Therapeutics' Change in Cash ranged from a high of $36.9 million in Q2 2023 and a low of -$37.0 million during Q3 2023.
  • Over the past 1 years, ADC Therapeutics' median Change in Cash value was -$24.0 million (recorded in 2023), while the average stood at -$12.0 million.